spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 8


Fig. 8. Expression of INPP5B alters trafficking of ERGIC53 in BFA-treated cells. (A) HeLa cells transiently expressing GFP-INPP5B (green) were incubated with 5 µg/ml BFA at 37°C for 20 minutes before fixation in paraformaldehyde and labelling with antibodies against ERGIC53, GM130 or GalNacT2 (red). (B) HeLa cells expressing GFP-INPP5B (green) were incubated with 5 µg/ml BFA for the indicated times and labelled with an antibody against ERGIC53 (red). (C) HeLa cells expressing GFP-INPP5B were incubated with or without 5 µg/ml BFA for 5 minutes and labelled with antibody against β-COP (red). (D) HeLa cells transiently expressing GFP-INPP5B or GFP-OCRL1 (green) were incubated with 5 µg/ml BFA for 20 minutes and labelled with antibody against ERGIC53. Bars, 10 µm.





Right arrow Return to article